However, patients carrying TLR2 del/del genotype showed an increased risk for HCC compared with all other groups of patients and BDs by using pair wise comparison test (one-way analysis of variance HCC vs NHL p = 0.004; Figure 2). Here, TLR2 is linked to non-Hodgkin lymphoma.